HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors

Por Takaori-Kondo, Akifumi, Shindo, Keisuke
Publicado em 2013

Evolution of HIV-1 Isolates that Use a Novel Vif-independent Mechanism to Resist Restriction by Human APOBEC3G

Por Haché, Guylaine, Shindo, Keisuke, Albin, John S., Harris, Reuben S.
Publicado em 2008

Features of Japanese juvenile spondyloarthritis patients in our hospital

Por Okamoto, Nami, Shindo, Keisuke, Shabana, Kosuke, Murata, Takuji, Tamai, Hiroshi
Publicado em 2014

Musculoskeletal ultrasound findings of articular manifestations on juvenile primary sjogren’s syndrome

Por Shabana, Kosuke, Okamoto, Nami, Shindo, Keisuke, Murata, Takuji, Tamai, Hiroshi, Fujiwara, Kenta
Publicado em 2014

APOBEC3G Targets Specific Virus Species

Por Kobayashi, Masayuki, Takaori-Kondo, Akifumi, Shindo, Keisuke, Abudu, Aierken, Fukunaga, Keiko, Uchiyama, Takashi
Publicado em 2004

Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G

Por Chen, Kuan-Ming, Martemyanova, Natalia, Lu, Yongjian, Shindo, Keisuke, Matsuo, Hiroshi, Harris, Reuben S.
Publicado em 2007

Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction

Por Refsland, Eric W., Stenglein, Mark D., Shindo, Keisuke, Albin, John S., Brown, William L., Harris, Reuben S.
Publicado em 2010

Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation

Por Matsui, Yusuke, Shindo, Keisuke, Nagata, Kayoko, Yoshinaga, Noriyoshi, Shirakawa, Kotaro, Kobayashi, Masayuki, Takaori-Kondo, Akifumi
Publicado no J Biol Chem (2016)

A Comparison of Two Single-Stranded DNA Binding Models by Mutational Analysis of APOBEC3G

Por Shindo, Keisuke, Li, Ming, Gross, Phillip J., Brown, William L., Harjes, Elena, Lu, Yongjian, Matsuo, Hiroshi, Harris, Reuben S.
Publicado em 2012

A Single Amino Acid in Human APOBEC3F Alters Susceptibility to HIV-1 Vif

Por Albin, John S., LaRue, Rebecca S., Weaver, Jessalyn A., Brown, William L., Shindo, Keisuke, Harjes, Elena, Matsuo, Hiroshi, Harris, Reuben S.
Publicado em 2010

APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells

Por Shinohara, Masanobu, Io, Katsuhiro, Shindo, Keisuke, Matsui, Masashi, Sakamoto, Takashi, Tada, Kohei, Kobayashi, Masayuki, Kadowaki, Norimitsu, Takaori-Kondo, Akifumi
Publicado em 2012

Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis

Por Matsui, Yusuke, Shindo, Keisuke, Nagata, Kayoko, Io, Katsuhiro, Tada, Kohei, Iwai, Fumie, Kobayashi, Masayuki, Kadowaki, Norimitsu, Harris, Reuben S, Takaori-Kondo, Akifumi
Publicado em 2013

Small molecules that inhibit Vif-induced degradation of APOBEC3G

Por Matsui, Masashi, Shindo, Keisuke, Izumi, Taisuke, Io, Katsuhiro, Shinohara, Masanobu, Komano, Jun, Kobayashi, Masayuki, Kadowaki, Norimitsu, Harris, Reuben S, Takaori-Kondo, Akifumi
Publicado em 2014

An Extended Structure of the APOBEC3G Catalytic Domain Suggests a Unique Holoenzyme Model

Por Harjes, Elena, Gross, Phillip J., Chen, Kuan-Ming, Lu, Yongjian, Shindo, Keisuke, Nowarski, Roni, Gross, John D., Kotler, Moshe, Harris, Reuben S., Matsuo, Hiroshi
Publicado em 2009

CKIP-1 Is an Intrinsic Negative Regulator of T-Cell Activation through an Interaction with CARMA1

Por Sakamoto, Takashi, Kobayashi, Masayuki, Tada, Kohei, Shinohara, Masanobu, Io, Katsuhiro, Nagata, Kayoko, Iwai, Fumie, Takiuchi, Yoko, Arai, Yasuyuki, Yamashita, Kouhei, Shindo, Keisuke, Kadowaki, Norimitsu, Koyanagi, Yoshio, Takaori-Kondo, Akifumi
Publicado em 2014

ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction

Por Miyakawa, Kei, Matsunaga, Satoko, Kanou, Kazuhiko, Matsuzawa, Atsushi, Morishita, Ryo, Kudoh, Ayumi, Shindo, Keisuke, Yokoyama, Masaru, Sato, Hironori, Kimura, Hirokazu, Tamura, Tomohiko, Yamamoto, Naoki, Ichijo, Hidenori, Takaori-Kondo, Akifumi, Ryo, Akihide
Publicado no Nat Commun (2015)

Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces

Por Shandilya, Shivender M. D., Nalam, Madhavi N. L., Nalivaika, Ellen A., Gross, Phillip J., Valesano, John C., Shindo, Keisuke, Li, Ming, Munson, Mary, Harjes, Elena, Kouno, Takahide, Matsuo, Hiroshi, Harris, Reuben S., Somasundaran, Mohan, Schiffer, Celia A.
Publicado em 2010

Abacavir, an anti–HIV-1 drug, targets TDP1-deficient adult T cell leukemia

Por Tada, Kohei, Kobayashi, Masayuki, Takiuchi, Yoko, Iwai, Fumie, Sakamoto, Takashi, Nagata, Kayoko, Shinohara, Masanobu, Io, Katsuhiro, Shirakawa, Kotaro, Hishizawa, Masakatsu, Shindo, Keisuke, Kadowaki, Norimitsu, Hirota, Kouji, Yamamoto, Junpei, Iwai, Shigenori, Sasanuma, Hiroyuki, Takeda, Shunichi, Takaori-Kondo, Akifumi
Publicado no Sci Adv (2015)

Vif hijacks CBF – β to degrade APOBEC3G and promote HIV–1 infection

Por Jäger, Stefanie, Kim, Dong Young, Hultquist, Judd F., Shindo, Keisuke, LaRue, Rebecca S., Kwon, Eunju, Li, Ming, Anderson, Brett D., Yen, Linda, Stanley, David, Mahon, Cathal, Kane, Joshua, Franks-Skiba, Kathy, Cimermancic, Peter, Burlingame, Alma, Sali, Andrej, Craik, Charles S., Harris, Reuben S., Gross, John D., Krogan, Nevan J.
Publicado em 2011